The service utilizes the Philips wearable ePatch paired with the company’s AI-driven Cardiologs analytics platform. Fourteen Spanish healthcare providers now use the ePatch extended-wear Holter monitors to detect arrhythmias like AFib.
Philips acquired ePatch through its $2.5 billion acquisition of BioTelemetry, which it completed in early 2021. The company acquired Cardiologs and its AI platform later that year. Previous data demonstrated the technology’s ability to detect arrhythmias missed by traditional Holter monitors. The system could also enhance patient comfort, improve care access and potentially provide better clinical outcomes while reducing costs.
ePatch provides data for up to 14 days of continuous monitoring. When paired with Cardiologs, it provides and end-to-end solution that helps hospitals detect and diagnose AFib. Applications include monitoring for AFib after cardiac ablation or heart valve replacement procedures. It can also help in studying the link between magnesium insufficiency and AFib, Philips said in a news release.
Dr. Jorge Pagola of University Hospital Vall d’Hebron, Barcelona, Spain, says the ePatch program helped expedite hospital discharges for 80 patients in 2023. This reduced the average length of stay while relieving emergency room pressure and reducing costs.
“This innovative new service allows clinical teams to conveniently monitor patients as they go about their everyday activities for extended periods of time, collecting the real-life data that helps reveal the patient’s true condition,” said Miquel Barras, ambulatory monitoring & diagnostics lead for Philips in Spain.
Philips just last week presented positive data on its AI-powered cardiac monitoring technology at HRS 2024. Read about all the top stories out of HRS 2024 HERE.
